Pancreatic Enzyme Replacement Therapy in Pancreatic Cancer - A Randomized Controlled Trial
Phase 4
- Conditions
- Cancer - PancreaticPancreatic Enzyme Insufficiency in Pancreatic Cancer
- Registration Number
- ACTRN12611001172998
- Lead Sponsor
- Dr. Anna McLiesh
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot yet recruiting
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Known, unresectable cancer of the pancreas
- Able to provide informed consent
Exclusion Criteria
- Resectable or resected pancreatic cancer
- Cannot obtain informed consent
- Chronic pancreatitis, coeliac disease, Chron's disease, previous gastric resections, Zollinger-Ellison syndrome
- Allergy to porcine products
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method